Authorization

Isracann Biosciences Advances Architectural and Security Plans for Israeli Project

VANCOUVER, British Columbia, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc.A (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the a??Companya??) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, today announced operational updates regarding the engagement of two leading consultancies within the early-stage Israeli cannabis sector.
AgroPlan Ltd. and A.R. Factor Group respectively provide the Company architectural design and security planning as part of an integrated design/build strategy aimed at earning key Good Practice national certifications encompassing several critical business and regulatory goals.AgroPlan was retained to prepare the architectural design and engineering drawings for the cultivation and harvest facilities. To complete the work, AgroPlan completed a site survey to assess the topography, drainage, access to water, roads and electricity. Using this information AgroPlan has engineered site specific/project specific architectural plan aimed at ensuring IMC-GAP, Israeli Medical Cannabis a?? Good Agricultural Practices code certification (Yakar Directive 151) and IMC-GMP, Israeli Medical Cannabis a?? Good Manufacturing Practices code certification (Yakar Directive 152).Concurrently, A.R, Factor Group was retained to prepare the security design of the cultivation and harvest facilities. The company reviewed the AgroPlan architectural designs and provided critical input to ensure the plans are suitable for and compliant with IMC-GSP, Israeli Medical Cannabis a?? Good Security Practices code (Yakar Directive 150). In addition to reviewing the architectural design, A.R. Factor was further contracted to write the requisite operational security plan for the entire site, which has been substantially completed.Company CEO Darryl Jones states, a??We are working through an anticipated diligence process with key national government agencies, principally under the auspices of the Ministry of Health (the a??Yakara??). Thanks largely to the decades of advanced research and understanding of our product and the rapidly growing global sector, we find ourselves working within a mature bureaucracy that respects and supportively engages with business interests. Engaging leading consultants to assist and guide us through the process helps ensure we meet our aggressive timelines and goals. We are very pleased to be working with the teams at AgroPlan and A.R. Factor group and are already benefitting greatly from their participation.a??
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Ноябрь 2019    »
ПнВтСрЧтПтСбВс
 123
45678910
11121314151617
18192021222324
252627282930